Learn how to rescue suboptimal formulations, improve bioavailability and scale efficiently with next-generation ASD approaches.

Biomarkers are reshaping oncology trial design (Sponsored)

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;